Phase II study with rituximab and CHOP [cyclophosphamide + doxorubicin + vincristine + prednisone] in patients with gastric diffuse large B-cell non-Hodgkin's lymphoma.
Phase of Trial: Phase II
Latest Information Update: 19 Oct 2008
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma; Gastric cancer
- Focus Therapeutic Use
- 19 Oct 2008 Actual patient number (30) added as reported by ClinicalTrials.gov.
- 19 Oct 2008 Status changed from recruiting to completed.
- 19 Oct 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.